
This Surging Pharma Company Could Hit Profitability by 2027
Nutriband Inc. is poised for a significant financial transformation, aiming for profitability by 2027. The company specializes in innovative transdermal pharmaceutical products. Nutriband faced a $6.8 million loss last year but anticipates an 85% annual growth rate. Debt is minimal, at only